Mark J. Holdbrook

Insider Reports History

Location
Irvine, CA
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Holdbrook:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. V.P., Clinical Affairs Restricted Stock Units 7,959 $129,811 $16.31 15 Mar 2023 Direct
Tarsus Pharmaceuticals, Inc. V.P., Clinical Affairs Common Stock 3,191 $63,820 $20.00 20 Mar 2023 Direct

Insider Reports Filed by Mark J. Holdbrook

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 17 Mar 2023 2 -$4,993 4 V.P., Clinical Affairs 21 Mar 2023, 19:06
TARS Tarsus Pharmaceuticals, Inc. 15 Mar 2023 3 -$2,511 4 V.P., Clinical Affairs 17 Mar 2023, 18:22
TARS Tarsus Pharmaceuticals, Inc. 09 Mar 2022 2 $0 4 V.P., Clinical Affairs 11 Mar 2022, 15:13